Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

NCT06641024 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, in Relapse
Refractory Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: MC-1-50

Sponsor

Chongqing Precision Biotech Co., Ltd

Collaborators

[object Object]